{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:49:07Z","timestamp":1761061747337,"version":"3.44.0"},"reference-count":23,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2022,10,13]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The possibility of hypercoagulability during the perioperative period of transcatheter aortic valve implantation (TAVI) has been noted; however, there is still a controversy regarding the appropriate perioperative antithrombotic therapy. The study investigated coagulation and platelet functions during the TAVI perioperative period using thromboelastography (TEG) 6s platelet mapping.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective observational study was conducted on 25 patients undergoing TAVI. TEG platelet mapping was performed at three time points: on admission to the operating room (before heparinisation), on postoperative day (POD) 1 and on POD 3. Perioperative changes observed included: maximum clot strength (MA<jats:sub>HKH<\/jats:sub>), clot strength without platelet function (MA<jats:sub>ActF<\/jats:sub>), time to initiation of clots formation by coagulation factors (R<jats:sub>HKH<\/jats:sub>) and platelet function (G<jats:sub>p<\/jats:sub>). G<jats:sub>p<\/jats:sub> is activated by thrombin, and not affected by antiplatelet agents. It is calculated as [(5000\u00d7MA<jats:sub>HKH<\/jats:sub>)\/(100 \u2013 MA<jats:sub>HKH<\/jats:sub>)] \u2212 [(5000\u00d7MA<jats:sub>ActF<\/jats:sub>)\/(100 \u2013 MA<jats:sub>ActF<\/jats:sub>)]. Finally, MA<jats:sub>ADP\/AA<\/jats:sub> and G<jats:sub>ADP\/AA<\/jats:sub>, which reflect clot strength and platelet aggregation mediated by ADP\/thromboxane A<jats:sub>2<\/jats:sub> receptors, respectively, were also examined using the same method as for G<jats:sub>p<\/jats:sub>.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>MA<jats:sub>HKH<\/jats:sub> continued to decrease until POD 3, indicating antithrombotic change after TAVI. G<jats:sub>p<\/jats:sub> continuously decreased for 3\u2009days after TAVI, while MA<jats:sub>ActF<\/jats:sub> increased significantly on POD 3. Furthermore, R<jats:sub>HKH<\/jats:sub> shortened on POD 1 and POD 3, suggesting increased coagulation capacity after TAVI. Finally, G<jats:sub>ADP<\/jats:sub> in clopidogrel-naive patients was reduced for 3\u2009days after TAVI, while G<jats:sub>AA<\/jats:sub> in aspirin-naive patients showed no significant change perioperatively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this study involving TEG platelet mapping, coagulation capacity increased while platelet function decreased, resulting in antithrombotic change for 3\u2009days after TAVI. The ADP receptor system may be implicated in the decreased platelet function. These results may be useful for considering optimal perioperative antithrombotic therapy in TAVI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2022-002132","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T09:33:15Z","timestamp":1667813595000},"page":"e002132","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Changes in platelet function and coagulation after transcatheter aortic valve implantation evaluated with thromboelastography"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6103-3194","authenticated-orcid":false,"given":"Mae","family":"Harada","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeyuki","family":"Sajima","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Onimaru","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Honjo","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-8450","authenticated-orcid":false,"given":"Hirofumi","family":"Hioki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5303","authenticated-orcid":false,"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-3851","authenticated-orcid":false,"given":"Shigehito","family":"Sawamura","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Teikyo University Hospital, Itabashi-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"2025081710425589000_9.2.e002132.1","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1097\/MJT.0000000000001413","article-title":"Risk of stroke after transcatheter aortic valve implantation: epidemiology, mechanism, and management","volume":"28","author":"Ciobanu","year":"2021","journal-title":"Am J Ther"},{"key":"2025081710425589000_9.2.e002132.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.010"},{"key":"2025081710425589000_9.2.e002132.3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5603\/KP.a2017.0225","article-title":"Thromboelastography for predicting bleeding in patients with aortic stenosis treated with transcatheter aortic valve implantation","volume":"76","author":"Rymuza","year":"2018","journal-title":"Kardiol Pol"},{"key":"2025081710425589000_9.2.e002132.4","first-page":"E177","article-title":"Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis","volume":"96","author":"Kuno","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025081710425589000_9.2.e002132.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.04.170"},{"key":"2025081710425589000_9.2.e002132.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.04.014"},{"key":"2025081710425589000_9.2.e002132.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.018"},{"key":"2025081710425589000_9.2.e002132.8","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001565","article-title":"Evaluation of latest viscoelastic coagulation assays in the transcatheter aortic valve implantation setting","volume":"8","author":"Fanning","year":"2021","journal-title":"Open Heart"},{"key":"2025081710425589000_9.2.e002132.9","doi-asserted-by":"crossref","DOI":"10.15836\/ccar2020.59","article-title":"Assessment of platelet function during transcatheter aortic valve implantation","volume":"15","author":"Ostoji\u0107","year":"2020","journal-title":"Cardiol Croat"},{"key":"2025081710425589000_9.2.e002132.10","first-page":"282","article-title":"Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients","volume":"13","author":"Li","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"2025081710425589000_9.2.e002132.11","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000859"},{"key":"2025081710425589000_9.2.e002132.12","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"2025081710425589000_9.2.e002132.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.01.332"},{"key":"2025081710425589000_9.2.e002132.14","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.21037\/apm-20-1728","article-title":"Platelet-fibrin clot strength measured by thromboelastography could predict hypercoagulability and antiplatelet effects in patients after percutaneous coronary intervention","volume":"10","author":"Yan","year":"2021","journal-title":"Ann Palliat Med"},{"key":"2025081710425589000_9.2.e002132.15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41401-019-0278-9","article-title":"Residual platelet reactivity is preferred over platelet inhibition rate in monitoring antiplatelet efficacy: insights using thrombelastography","volume":"41","author":"Wu","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"2025081710425589000_9.2.e002132.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.114.000669"},{"key":"2025081710425589000_9.2.e002132.17","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.15-290"},{"key":"2025081710425589000_9.2.e002132.18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79514"},{"key":"2025081710425589000_9.2.e002132.19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01689","article-title":"Ectonucleoside triphosphate diphosphohydrolase-1\/CD39 affects the response to ADP of female rat platelets","volume":"10","author":"Caiazzo","year":"2019","journal-title":"Front Pharmacol"},{"key":"2025081710425589000_9.2.e002132.20","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jtcvs.2018.05.042","article-title":"An in\u00a0vitro evaluation of turbulence after transcatheter aortic valve implantation","volume":"156","author":"Hatoum","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025081710425589000_9.2.e002132.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2014.12.050"},{"key":"2025081710425589000_9.2.e002132.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.07.041"},{"key":"2025081710425589000_9.2.e002132.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.05.034"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2022-002132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:43:03Z","timestamp":1755452583000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2022-002132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,11,7]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/openhrt-2022-002132"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2022-002132","relation":{},"ISSN":["2053-3624"],"issn-type":[{"type":"electronic","value":"2053-3624"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}